EMEA (Europe, Middle East and Africa) Insulin Like Growth Factor 1 Receptor Market Report 2017

January 2018 | 118 pages | ID: EDA1C74D5F1EN
QYResearch

Abstracts

In this report, the EMEA Insulin Like Growth Factor 1 Receptor market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Insulin Like Growth Factor 1 Receptor for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Insulin Like Growth Factor 1 Receptor market competition by top manufacturers/players, with Insulin Like Growth Factor 1 Receptor sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Astellas Pharma Inc.
• AstraZeneca Plc
• Axelar AB
• Boehringer Ingelheim GmbH
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• Genmab A/S
• Immunomedics, Inc.
• Insmed Incorporated
• Merck & Co., Inc.
• Merrimack Pharmaceuticals, Inc.
• Novartis AG
• PharmAbcine, Inc.
• ProteoThera, Inc.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• BI-893923
• CT-707
• 1R-E1
• ATL-1101
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Insulin Like Growth Factor 1 Receptor Market Report 2017

1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR OVERVIEW

1.1 Product Overview and Scope of Insulin Like Growth Factor 1 Receptor
1.2 Classification of Insulin Like Growth Factor 1 Receptor
  1.2.1 EMEA Insulin Like Growth Factor 1 Receptor Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Insulin Like Growth Factor 1 Receptor Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 BI-893923
  1.2.4 CT-707
  1.2.5 1R-E1
  1.2.6 ATL-1101
  1.2.7 Others
1.3 EMEA Insulin Like Growth Factor 1 Receptor Market by Application/End Users
  1.3.1 EMEA Insulin Like Growth Factor 1 Receptor Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 EMEA Insulin Like Growth Factor 1 Receptor Market by Region
  1.4.1 EMEA Insulin Like Growth Factor 1 Receptor Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Insulin Like Growth Factor 1 Receptor (2012-2022)
  1.5.1 EMEA Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Insulin Like Growth Factor 1 Receptor Revenue and Growth Rate (2012-2022)

2 EMEA INSULIN LIKE GROWTH FACTOR 1 RECEPTOR COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Insulin Like Growth Factor 1 Receptor Market Competition by Players/Manufacturers
  2.1.1 EMEA Insulin Like Growth Factor 1 Receptor Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Insulin Like Growth Factor 1 Receptor Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Insulin Like Growth Factor 1 Receptor Sale Price by Players (2012-2017)
2.2 EMEA Insulin Like Growth Factor 1 Receptor (Volume and Value) by Type/Product Category
  2.2.1 EMEA Insulin Like Growth Factor 1 Receptor Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Insulin Like Growth Factor 1 Receptor Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Insulin Like Growth Factor 1 Receptor Sale Price by Type (2012-2017)
2.3 EMEA Insulin Like Growth Factor 1 Receptor (Volume) by Application
2.4 EMEA Insulin Like Growth Factor 1 Receptor (Volume and Value) by Region
  2.4.1 EMEA Insulin Like Growth Factor 1 Receptor Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Insulin Like Growth Factor 1 Receptor Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Insulin Like Growth Factor 1 Receptor Sales Price by Region (2012-2017)

3 EUROPE INSULIN LIKE GROWTH FACTOR 1 RECEPTOR (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Insulin Like Growth Factor 1 Receptor Sales and Value (2012-2017)
  3.1.1 Europe Insulin Like Growth Factor 1 Receptor Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Insulin Like Growth Factor 1 Receptor Revenue and Growth Rate (2012-2017)
3.2 Europe Insulin Like Growth Factor 1 Receptor Sales and Market Share by Type
3.3 Europe Insulin Like Growth Factor 1 Receptor Sales and Market Share by Application
3.4 Europe Insulin Like Growth Factor 1 Receptor Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Insulin Like Growth Factor 1 Receptor Sales Volume by Countries (2012-2017)
  3.4.2 Europe Insulin Like Growth Factor 1 Receptor Revenue by Countries (2012-2017)
  3.4.3 Germany Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2012-2017)
  3.4.4 France Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2012-2017)
  3.4.5 UK Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2012-2017)
  3.4.6 Russia Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2012-2017)
  3.4.7 Italy Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2012-2017)

4 MIDDLE EAST INSULIN LIKE GROWTH FACTOR 1 RECEPTOR (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Insulin Like Growth Factor 1 Receptor Sales and Value (2012-2017)
  4.1.1 Middle East Insulin Like Growth Factor 1 Receptor Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Insulin Like Growth Factor 1 Receptor Revenue and Growth Rate (2012-2017)
4.2 Middle East Insulin Like Growth Factor 1 Receptor Sales and Market Share by Type
4.3 Middle East Insulin Like Growth Factor 1 Receptor Sales and Market Share by Application
4.4 Middle East Insulin Like Growth Factor 1 Receptor Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Insulin Like Growth Factor 1 Receptor Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Insulin Like Growth Factor 1 Receptor Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2012-2017)
  4.4.4 Israel Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2012-2017)
  4.4.5 UAE Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2012-2017)
  4.4.6 Iran Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2012-2017)

5 AFRICA INSULIN LIKE GROWTH FACTOR 1 RECEPTOR (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Insulin Like Growth Factor 1 Receptor Sales and Value (2012-2017)
  5.1.1 Africa Insulin Like Growth Factor 1 Receptor Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Insulin Like Growth Factor 1 Receptor Revenue and Growth Rate (2012-2017)
5.2 Africa Insulin Like Growth Factor 1 Receptor Sales and Market Share by Type
5.3 Africa Insulin Like Growth Factor 1 Receptor Sales and Market Share by Application
5.4 Africa Insulin Like Growth Factor 1 Receptor Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Insulin Like Growth Factor 1 Receptor Sales Volume by Countries (2012-2017)
  5.4.2 Africa Insulin Like Growth Factor 1 Receptor Revenue by Countries (2012-2017)
  5.4.3 South Africa Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2012-2017)

6 EMEA INSULIN LIKE GROWTH FACTOR 1 RECEPTOR MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Astellas Pharma Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Insulin Like Growth Factor 1 Receptor Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 AstraZeneca Plc
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Insulin Like Growth Factor 1 Receptor Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Axelar AB
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Insulin Like Growth Factor 1 Receptor Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Axelar AB Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Boehringer Ingelheim GmbH
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Insulin Like Growth Factor 1 Receptor Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Bristol-Myers Squibb Company
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Insulin Like Growth Factor 1 Receptor Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Eli Lilly and Company
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Insulin Like Growth Factor 1 Receptor Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 F. Hoffmann-La Roche Ltd.
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Insulin Like Growth Factor 1 Receptor Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Genmab A/S
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Insulin Like Growth Factor 1 Receptor Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Genmab A/S Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Immunomedics, Inc.
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Insulin Like Growth Factor 1 Receptor Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Insmed Incorporated
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Insulin Like Growth Factor 1 Receptor Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Merck & Co., Inc.
6.12 Merrimack Pharmaceuticals, Inc.
6.13 Novartis AG
6.14 PharmAbcine, Inc.
6.15 ProteoThera, Inc.

7 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR MANUFACTURING COST ANALYSIS

7.1 Insulin Like Growth Factor 1 Receptor Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Insulin Like Growth Factor 1 Receptor

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Insulin Like Growth Factor 1 Receptor Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Insulin Like Growth Factor 1 Receptor Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA INSULIN LIKE GROWTH FACTOR 1 RECEPTOR MARKET FORECAST (2017-2022)

11.1 EMEA Insulin Like Growth Factor 1 Receptor Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Insulin Like Growth Factor 1 Receptor Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Insulin Like Growth Factor 1 Receptor Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Insulin Like Growth Factor 1 Receptor Price and Trend Forecast (2017-2022)
11.2 EMEA Insulin Like Growth Factor 1 Receptor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Insulin Like Growth Factor 1 Receptor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Insulin Like Growth Factor 1 Receptor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Insulin Like Growth Factor 1 Receptor Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Insulin Like Growth Factor 1 Receptor Sales Forecast by Type (2017-2022)
11.7 EMEA Insulin Like Growth Factor 1 Receptor Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Insulin Like Growth Factor 1 Receptor
Figure EMEA Insulin Like Growth Factor 1 Receptor Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Insulin Like Growth Factor 1 Receptor Sales Volume Market Share by Type (Product Category) in 2016
Figure BI-893923 Product Picture
Figure CT-707 Product Picture
Figure 1R-E1 Product Picture
Figure ATL-1101 Product Picture
Figure Others Product Picture
Figure EMEA Insulin Like Growth Factor 1 Receptor Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Insulin Like Growth Factor 1 Receptor by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Insulin Like Growth Factor 1 Receptor Market Size (Million USD) by Region (2012-2022)
Figure Europe Insulin Like Growth Factor 1 Receptor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Insulin Like Growth Factor 1 Receptor Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Insulin Like Growth Factor 1 Receptor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Insulin Like Growth Factor 1 Receptor Revenue (Million USD) Status and Forecast by Countries
Figure Africa Insulin Like Growth Factor 1 Receptor Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Insulin Like Growth Factor 1 Receptor Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Insulin Like Growth Factor 1 Receptor Sales Volume and Growth Rate (2012-2022)
Figure EMEA Insulin Like Growth Factor 1 Receptor Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Insulin Like Growth Factor 1 Receptor Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Insulin Like Growth Factor 1 Receptor Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Insulin Like Growth Factor 1 Receptor Sales Share by Players (2012-2017)
Figure 2016 Insulin Like Growth Factor 1 Receptor Sales Share by Players
Figure 2017 Insulin Like Growth Factor 1 Receptor Sales Share by Players
Figure EMEA Insulin Like Growth Factor 1 Receptor Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Insulin Like Growth Factor 1 Receptor Revenue (Million USD) by Players (2012-2017)
Table EMEA Insulin Like Growth Factor 1 Receptor Revenue Share by Players (2012-2017)
Table 2016 EMEA Insulin Like Growth Factor 1 Receptor Revenue Share by Players
Table 2017 EMEA Insulin Like Growth Factor 1 Receptor Revenue Share by Players
Table EMEA Insulin Like Growth Factor 1 Receptor Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Insulin Like Growth Factor 1 Receptor Sales Share by Type (2012-2017)
Figure Sales Market Share of Insulin Like Growth Factor 1 Receptor by Type (2012-2017)
Figure EMEA Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2012-2017)
Table EMEA Insulin Like Growth Factor 1 Receptor Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Insulin Like Growth Factor 1 Receptor Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Insulin Like Growth Factor 1 Receptor by Type in 2016
Table EMEA Insulin Like Growth Factor 1 Receptor Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Insulin Like Growth Factor 1 Receptor Sales Share by Application (2012-2017)
Figure Sales Market Share of Insulin Like Growth Factor 1 Receptor by Application (2012-2017)
Figure EMEA Insulin Like Growth Factor 1 Receptor Sales Market Share by Application in 2016
Table EMEA Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Insulin Like Growth Factor 1 Receptor Sales Share by Region (2012-2017)
Figure Sales Market Share of Insulin Like Growth Factor 1 Receptor by Region (2012-2017)
Figure EMEA Insulin Like Growth Factor 1 Receptor Sales Market Share in 2016
Table EMEA Insulin Like Growth Factor 1 Receptor Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Insulin Like Growth Factor 1 Receptor Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Insulin Like Growth Factor 1 Receptor by Region (2012-2017)
Figure EMEA Insulin Like Growth Factor 1 Receptor Revenue Market Share Regions in 2016
Table EMEA Insulin Like Growth Factor 1 Receptor Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Insulin Like Growth Factor 1 Receptor Revenue and Growth Rate (2012-2017)
Table Europe Insulin Like Growth Factor 1 Receptor Sales (K Pcs) by Type (2012-2017)
Table Europe Insulin Like Growth Factor 1 Receptor Market Share by Type (2012-2017)
Figure Europe Insulin Like Growth Factor 1 Receptor Market Share by Type in 2016
Table Europe Insulin Like Growth Factor 1 Receptor Sales (K Pcs) by Application (2012-2017)
Table Europe Insulin Like Growth Factor 1 Receptor Market Share by Application (2012-2017)
Figure Europe Insulin Like Growth Factor 1 Receptor Market Share by Application in 2016
Table Europe Insulin Like Growth Factor 1 Receptor Sales (K Pcs) by Countries (2012-2017)
Table Europe Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries (2012-2017)
Figure Europe Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries (2012-2017)
Figure Europe Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries in 2016
Table Europe Insulin Like Growth Factor 1 Receptor Revenue (Million USD) by Countries (2012-2017)
Table Europe Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries (2012-2017)
Figure Europe Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries (2012-2017)
Figure Europe Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries in 2016
Figure Germany Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Insulin Like Growth Factor 1 Receptor Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Insulin Like Growth Factor 1 Receptor Sales (K Pcs) by Type (2012-2017)
Table Middle East Insulin Like Growth Factor 1 Receptor Market Share by Type (2012-2017)
Figure Middle East Insulin Like Growth Factor 1 Receptor Market Share by Type (2012-2017)
Table Middle East Insulin Like Growth Factor 1 Receptor Sales (K Pcs) by Applications (2012-2017)
Table Middle East Insulin Like Growth Factor 1 Receptor Market Share by Applications (2012-2017)
Figure Middle East Insulin Like Growth Factor 1 Receptor Sales Market Share by Application in 2016
Table Middle East Insulin Like Growth Factor 1 Receptor Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Insulin Like Growth Factor 1 Receptor Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Insulin Like Growth Factor 1 Receptor Sales Volume Market Share by Countries in 2016
Table Middle East Insulin Like Growth Factor 1 Receptor Revenue (Million USD) by Countries (2012-2017)
Table Middle East Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries (2012-2017)
Figure Middle East Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries (2012-2017)
Figure Middle East Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries in 2016
Figure Saudi Arabia Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Insulin Like Growth Factor 1 Receptor Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Insulin Like Growth Factor 1 Receptor Sales (K Pcs) by Type (2012-2017)
Table Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2012-2017)
Figure Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Type (2012-2017)
Figure Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Type in 2016
Table Africa Insulin Like Growth Factor 1 Receptor Sales (K Pcs) by Application (2012-2017)
Table Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2012-2017)
Figure Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2012-2017)
Table Africa Insulin Like Growth Factor 1 Receptor Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries (2012-2017)
Figure Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries (2012-2017)
Figure Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries in 2016
Table Africa Insulin Like Growth Factor 1 Receptor Revenue (Million USD) by Countries (2012-2017)
Table Africa Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries (2012-2017)
Figure Africa Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries (2012-2017)
Figure Africa Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries in 2016
Figure South Africa Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Table Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Basic Information List
Table Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales Market Share in EMEA (2012-2017)
Figure Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Revenue Market Share in EMEA (2012-2017)
Table AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Basic Information List
Table AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales Market Share in EMEA (2012-2017)
Figure AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Revenue Market Share in EMEA (2012-2017)
Table Axelar AB Insulin Like Growth Factor 1 Receptor Basic Information List
Table Axelar AB Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Axelar AB Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Axelar AB Insulin Like Growth Factor 1 Receptor Sales Market Share in EMEA (2012-2017)
Figure Axelar AB Insulin Like Growth Factor 1 Receptor Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Basic Information List
Table Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales Market Share in EMEA (2012-2017)
Figure Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Revenue Market Share in EMEA (2012-2017)
Table Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Basic Information List
Table Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales Market Share in EMEA (2012-2017)
Figure Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Basic Information List
Table Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Revenue Market Share in EMEA (2012-2017)
Table F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Basic Information List
Table F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales Market Share in EMEA (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Revenue Market Share in EMEA (2012-2017)
Table Genmab A/S Insulin Like Growth Factor 1 Receptor Basic Information List
Table Genmab A/S Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Genmab A/S Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Genmab A/S Insulin Like Growth Factor 1 Receptor Sales Market Share in EMEA (2012-2017)
Figure Genmab A/S Insulin Like Growth Factor 1 Receptor Revenue Market Share in EMEA (2012-2017)
Table Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Basic Information List
Table Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales Market Share in EMEA (2012-2017)
Figure Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Revenue Market Share in EMEA (2012-2017)
Table Insmed Incorporated Insulin Like Growth Factor 1 Receptor Basic Information List
Table Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate (2012-2017)
Figure Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales Market Share in EMEA (2012-2017)
Figure Insmed Incorporated Insulin Like Growth Factor 1 Receptor Revenue Market Share in EMEA (2012-2017)
Table Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Basic Information List
Table Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Basic Information List
Table Novartis AG Insulin Like Growth Factor 1 Receptor Basic Information List
Table PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Basic Information List
Table ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Insulin Like Growth Factor 1 Receptor
Figure Manufacturing Process Analysis of Insulin Like Growth Factor 1 Receptor
Figure Insulin Like Growth Factor 1 Receptor Industrial Chain Analysis
Table Raw Materials Sources of Insulin Like Growth Factor 1 Receptor Major Manufacturers in 2016
Table Major Buyers of Insulin Like Growth Factor 1 Receptor
Table Distributors/Traders List
Figure EMEA Insulin Like Growth Factor 1 Receptor Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Insulin Like Growth Factor 1 Receptor Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Insulin Like Growth Factor 1 Receptor Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Insulin Like Growth Factor 1 Receptor Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Insulin Like Growth Factor 1 Receptor Sales Market Share Forecast by Region (2017-2022)
Table EMEA Insulin Like Growth Factor 1 Receptor Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Insulin Like Growth Factor 1 Receptor Revenue Market Share Forecast by Region (2017-2022)
Table Europe Insulin Like Growth Factor 1 Receptor Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Insulin Like Growth Factor 1 Receptor Sales Market Share Forecast by Countries (2017-2022)
Table Europe Insulin Like Growth Factor 1 Receptor Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Insulin Like Growth Factor 1 Receptor Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Insulin Like Growth Factor 1 Receptor Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Insulin Like Growth Factor 1 Receptor Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Insulin Like Growth Factor 1 Receptor Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Insulin Like Growth Factor 1 Receptor Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Insulin Like Growth Factor 1 Receptor Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Insulin Like Growth Factor 1 Receptor Sales Market Share Forecast by Countries (2017-2022)
Table Africa Insulin Like Growth Factor 1 Receptor Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Insulin Like Growth Factor 1 Receptor Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Insulin Like Growth Factor 1 Receptor Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Insulin Like Growth Factor 1 Receptor Sales Market Share Forecast by Type (2017-2022)
Table EMEA Insulin Like Growth Factor 1 Receptor Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Insulin Like Growth Factor 1 Receptor Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources